Skip to main content

Table 4 Factors associated with non-adherence to antidiabetic medication among patients with type 2 diabetes in Limbe and Bamenda Regional Hospitals, Cameroon, 2016

From: Adherence to antidiabetic medication and factors associated with non-adherence among patients with type-2 diabetes mellitus in two regional hospitals in Cameroon

Variable OR (95% CI) Adjusted OR (95% CI) p-value
Age (in years)
 ≤ 60    0.02*
 > 60 0.44 (0.25–0.78) 0.48 (0.25–0.94)
Educational level
 Never gone to school
  Primary 2.74 (1.24–6.08) 1.71 (0.71–4.10) 0.52*
  Secondary 3.57 (1.40–9.08) 1.58 (0.54–4.62)
  High school /University 3.08 (1.17–8.07) 1.60 (0.49–5.20)
Gender
 Female    0.81*
 Male 1.39 (0.75–2.60) 1.07 (0.05–2.28)
Body-Mass Index, BMI (kg/m2) 0.99 (0.97–1.01)   0.55
Co-morbidity
 Hypertension    0.35
  No   
  Yes 0.76 (0.42–1.36)  
 Chronic renal disease
  No    0.35
  Yes 2.13 (0.40–11.25)  
 Stroke    0.51
  No   
  Yes 0.54 (0.09–3.34)  
Duration of diabetes (in years)
 < 5 years    0.22
 6–10 years 2.28 (1.08–4.84)  
 11–20 years 1.69 (0.82–3.50)  
 > 20 years 0.53 (0.13–2.26)  
Alcohol consumption
 No    0.04*
 Yes 2.05 (1.13–3.72) 2.13 (1.10–4.14)
Tobacco use
 No    0.67
 Yes 1.67 (0.15–18.76)  
Number of diabetic complications
 None    0.54
  1 1.34 (0.72–2.49)  
  2 or more 1.46 (0.64–3.35)  
Current antidiabetic medications
 Single OHA
  Two OHA 1.25 (0.63–2.50) 1.16 (0.56–2.42) 0.04*
  Insulin alone 3.15 (1.19–8.34) 2.85 (1.01–8.08)
  Insulin and OHA 2.22 (0.95–5.20) 0.78 (0.76–4.71)
  1. *p-value on multivariable analysis, OHA oral hypoglycaemic agent, BMI body mass index, ref. reference, OR odds ratio, CI confidence interval